Scarica l'app Stockscreener
68.66
0.04%
0.03
Precedente Chiudi:
$68.63
Aprire:
$67.91
Volume 24 ore:
897.24K
Relative Volume:
0.47
Capitalizzazione di mercato:
$6.15B
Reddito:
$288.07M
Utile/perdita netta:
$22.31M
Rapporto P/E:
484.89
EPS:
0.1416
Flusso di cassa netto:
$41.15M
1 W Prestazione:
+1.43%
1M Prestazione:
-22.31%
6M Prestazione:
+99.71%
1 anno Prestazione:
+138.07%
Intervallo 1D:
$67.40
$69.47
Intervallo di 1 settimana:
$66.10
$70.75
Portata 52W:
$21.14
$93.61
Liquidia Corp Stock (LQDA) Company Profile
Nome
Liquidia Corp
Settore
Telefono
919.328.4400
Indirizzo
419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC
Compare LQDA vs TAK, TEVA, HLN, ZTS, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LQDA
Liquidia Corp
|
68.66 | 6.36B | 288.07M | 22.31M | 41.15M | 0.1416 |
TAK
Takeda Pharmaceutical Co Adr
|
18.45 | 57.90B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
36.36 | 42.89B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.60 | 43.41B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
75.81 | 31.00B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
487.61 | 22.35B | 3.17B | 1.29B | 1.01B | 27.09 |
Liquidia Corp Stock (LQDA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-20 | Iniziato | Wells Fargo | Overweight |
| 2025-08-15 | Ripresa | Jefferies | Buy |
| 2025-05-19 | Downgrade | Oppenheimer | Perform → Underperform |
| 2024-12-20 | Iniziato | Wells Fargo | Overweight |
| 2024-10-16 | Iniziato | Scotiabank | Sector Outperform |
| 2024-08-19 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2024-08-16 | Iniziato | Raymond James | Outperform |
| 2024-06-25 | Iniziato | Oppenheimer | Perform |
| 2024-01-05 | Reiterato | Needham | Buy |
| 2022-09-19 | Ripresa | Wedbush | Underperform |
| 2022-09-01 | Downgrade | Wedbush | Neutral → Underperform |
| 2022-07-22 | Iniziato | Ladenburg Thalmann | Buy |
| 2022-05-31 | Iniziato | BTIG Research | Buy |
| 2022-05-26 | Iniziato | BofA Securities | Buy |
| 2020-12-04 | Iniziato | H.C. Wainwright | Buy |
| 2020-11-20 | Downgrade | Wedbush | Outperform → Neutral |
| 2018-11-08 | Ripresa | Jefferies | Buy |
| 2018-09-05 | Iniziato | Wedbush | Outperform |
| 2018-08-20 | Iniziato | Jefferies | Buy |
| 2018-08-20 | Iniziato | Needham | Buy |
Mostra tutto
Liquidia Corp Borsa (LQDA) Ultime notizie
Liquidia Slips as Post-Earnings Selling Continues - Quiver Quantitative
Liquidia (NASDAQ:LQDA) Director Katherine Rielly-Gauvin Sells 36,789 Shares of Stock - MarketBeat
Insider at Liquidia (NASDAQ: LQDA) plans multimillion-dollar stock sale - Stock Titan
Liquidia (NASDAQ: LQDA) director sells 55K shares in 10b5-1 trades - Stock Titan
Liquidia Corp (LQDA) Shares Fall 5.8% -- What GF Score of 70 Tel - GuruFocus
Liquidia CEO Roger Jeffs Says Demand For Inhaled Lung Disease Drug Is Growing Amid Q2 Revenue Beat - Stocktwits
Liquidia Corp (LQDA) CMO cashes in options, unloads 79K+ shares - Stock Titan
Liquidia (NASDAQ: LQDA) director to sell shares after option exercises - Stock Titan
Liquidia (NASDAQ: LQDA) officer eyes $3.7M Rule 144 stock resale - Stock Titan
Can Yutrepia's Strong Growth Drive Liquidia's PAH Expansion? - Zacks Investment Research
Renaissance Technologies LLC Sells 198,753 Shares of Liquidia Corporation $LQDA - MarketBeat
A Look at Liquidia Corp (LQDA) After 4.3% Gain -- GF Value $267. - GuruFocus
Liquidia (NASDAQ: LQDA) affiliate plans new stock sale after $710K July trade - Stock Titan
LQDA Stock Down Post Q2 Earnings Release: What Should Investors Do Now? - Yahoo Finance
Greenhaven Road Capital: Short Term Gain Realized from Liquidia (LQDA), Investment to Be Revisited - Yahoo Finance
Liquidia (NASDAQ:LQDA) Rating Lowered to "Hold" at Zacks Research - MarketBeat
Teleconferência de Resultados do 2T26 da Liquidia (LQDA): Vendas do YUTREPIA Crescem 31% - TradingKey
Liquidia Corp (LQDA) sees 6.5% stake reported by investor Paul B. Manning - Stock Titan
HC Wainwright Brokers Lower Earnings Estimates for Liquidia - MarketBeat
Liquidia (LQDA) Q2 2026 Earnings Call: YUTREPIA Sales Rise 31% - TradingKey
Why Liquidia Stock Was Diving This Week - The Globe and Mail
Why Liquidia Stock Was Diving This Week - The Motley Fool
Liquidia (LQDA) Stock May Trade At A Premium On Earnings But A Discount On Broader Checks - Yahoo Finance
Liquidia Corp (LQDA) Shares Fall 8.5% -- What GF Score of 70 Tel - GuruFocus
Liquidia (NASDAQ:LQDA) Trading Down 6.6% Following Weak Earnings - MarketBeat
LQDA Q2 Earnings Top, Strong Yutrepia Sales Fuel Top-Line Growth - TradingView
LQDA Maintained by Wells Fargo -- Price Target Raised to $108.00 - GuruFocus
LQDA Q2 Earnings Call Highlights YUTREPIA and $1B 2027 Revenue Path - Yahoo Finance
Liquidia (NASDAQ:LQDA) Price Target Raised to $92.00 - MarketBeat
LQDA Maintained by B of A Securities -- Price Target Raised to $92 - GuruFocus
Liquidia (NASDAQ:LQDA): What Does the Latest Update Mean for Product Adoption? - Kalkine Media
LGL PARTNERS, LLC's Liquidia Corp(LQDA) Holding History - GuruFocus
LQDA SWOT Analysis: Strong Revenue Growth and Strategic Opportunities Revealed in 10-Q Filing - GuruFocus
Liquidia Corporation (LQDA) Stock Forecasts - Yahoo Finance
Liquidia Corp (LQDA) (Q2 2026) Earnings Call Highlights: YUTREPI - GuruFocus
Liquidia Corp (LQDA) (Q2 2026) Earnings Call Highlights: YUTREPIA Sales Surge 31% as Company ... - Yahoo Finance
Liquidia (LQDA) Turns Profitable In Q2, Is The Pullback A Valuation Opportunity? - simplywall.st
LQDA Downgraded by LifeSci Capital -- Rating Adjusted to Market Perform - GuruFocus
Liquidia Corporation Q2 2026 Earnings Call Summary - Yahoo Finance
LQDA Maintains by BTIG -- Price Target Raised to $111.00 - GuruFocus
Needham & Company LLC Issues Positive Forecast for Liquidia (NASDAQ:LQDA) Stock Price - marketbeat.com
BTIG Research Raises Liquidia (NASDAQ:LQDA) Price Target to $111.00 - marketbeat.com
Liquidia (NASDAQ:LQDA) Receives Market Perform Rating from Lifesci Capital - MarketBeat
10 Health Care Stocks With Whale Alerts In Today’s Session - Benzinga
Liquidia (NASDAQ:LQDA) Announces Earnings Results - MarketBeat
Why Liquidia Corporation (LQDA) Stock Is Down Today - Quiver Quantitative
Liquidia Q2 Earnings Call Highlights - MarketBeat
Liquidia (NASDAQ:LQDA) Shares Gap Down Following Weak Earnings - MarketBeat
Earnings call transcript: Liquidia misses EPS in Q2 2026 as YUTREPIA sales surge - Investing.com Nigeria
Liquidia Corporation Reports Q2 2026 Financial Results and Updates on Pipeline, Litigation, and Commercial Activities - Kalkine Media
Liquidia Q2 2026 slides: YUTREPIA sales surge 31%, 10 studies underway - Investing.com
Liquidia Corp Azioni (LQDA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Liquidia Corp Azioni (LQDA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Adair Jason | Chief Business Officer |
Aug 21 '26 |
Sale |
69.09 |
73,631 |
5,087,225 |
174,606 |
1.66%
0.33%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):